MedEngine is a digitally minded, people-first, premium partner for pharmaceutical and health-tech industries. We bridge medical science with business to help our clients achieve their goals and enable patient access to the latest innovations. We accelerate the future of care through smart solutions across real-world evidence, market access, medical affairs, and commercial excellence. Our team combines academic expertise with industry know-how and creative thinking to turn complex challenges into clear, impactful outcomes. Driven by a shared ambition, we are on a journey to become a global leader in transforming scientific knowledge into improved treatment opportunities. MedEngine is part of VCLS, an international organisation of more than 300 life sciences professionals dedicated to advancing innovative therapies for patients. VCLS provides integrated solutions across development planning, manufacturing, quality control, nonclinical and clinical testing, clinical trial operations, safety monitoring, and regulatory registration.
Looking for a particular MedEngine employee's phone or email?
The MedEngine annual revenue was $2 million in 2026.
Tero Ylisaukko-Oja is the CEO, founder of MedEngine.
24 people are employed at MedEngine.
MedEngine is based in Helsinki, Uusimaa.
The NAICS codes for MedEngine are [5417, 54, 541, 541713, 54171].
The SIC codes for MedEngine are [873, 87].